Iqvia (NYSE:IQV) issued an update on its FY18 earnings guidance on Wednesday morning. The company provided earnings per share guidance of $5.35-5.60 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.34. The company issued revenue guidance of $8.45-8.65 billion, compared to the consensus revenue estimate of $8.53 billion.Iqvia also updated its Q1 guidance to $1.23-1.30 EPS.

Iqvia (NYSE IQV) traded up $7.45 during trading on Wednesday, reaching $107.51. 505,617 shares of the company’s stock traded hands, compared to its average volume of 1,115,704. The company has a debt-to-equity ratio of 1.29, a quick ratio of 1.22 and a current ratio of 1.22. The firm has a market capitalization of $20,810.00, a price-to-earnings ratio of 345.03, a price-to-earnings-growth ratio of 1.34 and a beta of 0.61. Iqvia has a 12-month low of $75.94 and a 12-month high of $110.67.

Several research analysts have issued reports on IQV shares. TheStreet upgraded shares of Iqvia from a c+ rating to a b rating in a research report on Wednesday, December 13th. Zacks Investment Research raised shares of Iqvia from a hold rating to a buy rating and set a $114.00 price objective for the company in a research note on Saturday, October 21st. Stifel Nicolaus raised shares of Iqvia from a hold rating to a buy rating and raised their price objective for the stock from $92.00 to $128.00 in a research note on Friday, October 27th. Jefferies Group raised their price objective on shares of Iqvia from $107.00 to $110.00 and gave the stock a hold rating in a research note on Monday, October 30th. Finally, SunTrust Banks reaffirmed a hold rating and issued a $114.00 price objective on shares of Iqvia in a research note on Friday, November 3rd. Seven investment analysts have rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company’s stock. Iqvia presently has an average rating of Buy and a consensus target price of $109.71.

In other Iqvia news, major shareholder Cpp Investment Board Private H sold 7,497,807 shares of Iqvia stock in a transaction on Thursday, November 30th. The shares were sold at an average price of $102.00, for a total transaction of $764,776,314.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director John Connaughton sold 1,163,191 shares of Iqvia stock in a transaction on Thursday, November 30th. The shares were sold at an average price of $102.00, for a total transaction of $118,645,482.00. The disclosure for this sale can be found here. Insiders sold a total of 8,727,078 shares of company stock valued at $890,124,079 in the last ninety days. Company insiders own 6.40% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Iqvia (IQV) Updates FY18 Earnings Guidance” was published by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this piece on another publication, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this piece can be accessed at https://theolympiareport.com/2018/02/14/iqvia-iqv-updates-fy18-earnings-guidance.html.

About Iqvia

IQVIA Holdings Inc, formerly Quintiles IMS Holdings, Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Receive News & Ratings for Iqvia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia and related companies with MarketBeat.com's FREE daily email newsletter.